May 10, 2018
Successful commercialization of gut microbe strain could net Mayo $55M
Twin Cities Business by Don Jacobson If biotech firm Evelo Biosciences is successful enough in commercializing its lead anti-inflammatory drug candidate — made by using a strain of human gut microbe licensed from the Mayo Clinic — the Rochester institution’s ultimate payday could be as much as $55 million. That and other information regarding Mayo’s […]
Tags: Evelo Biosciences, gut microbiome, Mayo Clinic Ventures, Twin Cities Business
November 22, 2017
Mayo Clinic in the News Weekly Highlights for November 22, 2017
Washington Post, A standing desk isn’t going to help you lose a lot of weight by Rachel Rettner — The findings mean that, for a person who weighs about 140 pounds, substituting sitting with standing for six hours a day would burn an extra 54 calories per day, the researchers said. This […]
Tags: alzheimer's disease, back pain, blood pressure, brain surgery, Cancer, conjoined twins, Deanne Rothbauer, Dr. Bernard Bendok, Dr. Chetna Mangat, Dr. Colin West, Dr. David Dodick, Dr. David Knopman